Jeddah, Saudi Arabia: Jeddah Health Cluster 2 has signed a cooperation agreement with Jamjoom Pharma to strengthen collaboration in healthcare education, disease awareness, and professional capability development across Saudi Arabia.
The partnership aims to enhance healthcare quality by implementing health awareness campaigns, scientific and educational programmes, training activities, and knowledge exchange across multiple medical specialties. The initiative will support the continuous professional development of healthcare practitioners while promoting evidence-based clinical practices.
Also read: Clinical and Academic Collaboration to Advance Thoracic Cancer Care in the UAE
The agreement aligns with Jeddah Health Cluster 2’s strategic goals of improving healthcare services, empowering healthcare professionals, and strengthening partnerships that contribute to better patient outcomes.
It also supports the objectives of Saudi Vision 2030 by advancing healthcare workforce development, improving service quality, and fostering collaboration between the public and private sectors.
Click here to join our WhatsApp channel here
The agreement was signed by Dr. Shadi bin Salem Al Khayyat, Chief Executive Officer of Jeddah Health Cluster 2, and Dr. Essam Gameel Al Sayed, General Manager for Consumer Health at Jamjoom Pharma Saudi Arabia.
Dr. Essam Gameel Al Sayed, General Manager at Jamjoom Pharma Saudi Arabia and representative of this cooperation, said: “This partnership reflects the importance of integration between the public and private sectors in supporting health awareness and developing medical knowledge, contributing to the transfer of specialized expertise and enhancing the quality of health services in line with the best modern practices.”
